Sofija Stojanov-Jovanovic

Belgrade, SE, Serbia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Isorhamnetin Modulates Drug-Resistance-Related Biomarkers in Colon Cancer Cells.

Isorhamnetin Modulates Drug-Resistance-Related Biomarkers in Colon Cancer Cells.

Journal: International journal of molecular sciences

Published: May 27, 2025

Cancer 3D Models: Essential Tools for Understanding and Overcoming Drug Resistance.

Cancer 3D Models: Essential Tools for Understanding and Overcoming Drug Resistance.

Journal: Oncology research

Published: April 25, 2025

Associating Patient Responses with Drug Sensitivity in Non-Small Cell Lung Carcinoma Using an Immunoassay on Patient-Derived Cell Cultures.

Associating Patient Responses with Drug Sensitivity in Non-Small Cell Lung Carcinoma Using an Immunoassay on Patient-Derived Cell Cultures.

Journal: Current issues in molecular biology

Published: March 07, 2025

LB-100 Enhances Drugs Efficacy Through Inhibition of P-Glycoprotein Expression in Multidrug-Resistant Glioblastoma and Non-Small Cell Lung Carcinoma Cellular Models.

LB-100 Enhances Drugs Efficacy Through Inhibition of P-Glycoprotein Expression in Multidrug-Resistant Glioblastoma and Non-Small Cell Lung Carcinoma Cellular Models.

Journal: Pharmaceutics

Published: December 12, 2024

Cancer Patient-Derived Cell-Based Models: Applications and Challenges in Functional Precision Medicine.

Cancer Patient-Derived Cell-Based Models: Applications and Challenges in Functional Precision Medicine.

Journal: Life (Basel, Switzerland)

Published: July 31, 2024

Unveiling Anticancer Potential of COX-2 and 5-LOX Inhibitors: Cytotoxicity, Radiosensitization Potential and Antimigratory Activity against Colorectal and Pancreatic Carcinoma.

Unveiling Anticancer Potential of COX-2 and 5-LOX Inhibitors: Cytotoxicity, Radiosensitization Potential and Antimigratory Activity against Colorectal and Pancreatic Carcinoma.

Journal: Pharmaceutics

Published: May 03, 2024

Multidrug-Resistant Profiles in Non-Small Cell Lung Carcinoma Patient-Derived Cells: Implications for Personalized Approaches with Tyrosine Kinase Inhibitors.

Multidrug-Resistant Profiles in Non-Small Cell Lung Carcinoma Patient-Derived Cells: Implications for Personalized Approaches with Tyrosine Kinase Inhibitors.

Journal: Cancers

Published: April 26, 2024

Immunofluorescence-Based Assay for High-Throughput Analysis of Multidrug Resistance Markers in Non-Small Cell Lung Carcinoma Patient-Derived Cells.

Immunofluorescence-Based Assay for High-Throughput Analysis of Multidrug Resistance Markers in Non-Small Cell Lung Carcinoma Patient-Derived Cells.

Journal: Diagnostics (Basel, Switzerland)

Published: November 14, 2023

Coleon U, Isolated from Plectranthus mutabilis Codd., Decreases P-Glycoprotein Activity Due to Mitochondrial Inhibition.

Coleon U, Isolated from Plectranthus mutabilis Codd., Decreases P-Glycoprotein Activity Due to Mitochondrial Inhibition.

Journal: Pharmaceutics

Published: May 30, 2023

Biotinylated selenocyanates: Potent and selective cytostatic agents.

Biotinylated selenocyanates: Potent and selective cytostatic agents.

Journal: Bioorganic chemistry

Published: December 08, 2022

Alpha-1 antitrypsin expression is upregulated in multidrug-resistant cancer cells.

Alpha-1 antitrypsin expression is upregulated in multidrug-resistant cancer cells.

Journal: Histochemistry and cell biology

Published: December 07, 2022

Autophagy Inhibition Enhances Anti-Glioblastoma Effects of Pyrazolo[3,4-d]pyrimidine Tyrosine Kinase Inhibitors.

Autophagy Inhibition Enhances Anti-Glioblastoma Effects of Pyrazolo[3,4-d]pyrimidine Tyrosine Kinase Inhibitors.

Journal: Life (Basel, Switzerland)

Published: August 15, 2022

Showing 1-12 of 19

Last Updated: 09/26/2026